Jupiter Neurosciences (JUNS) Earnings Date & Reports

Jupiter Neurosciences Inc is a clinical-stage research and development company focused on developing treatments for neuroinflammation through the resveratrol platform... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

JUNS is expected to report earnings to rise 6,150.00% to -375 cents per share on December 02

Jupiter Neurosciences JUNS Stock Earnings Reports

Q3'26

Est.

$-3.75

Q1'26

Missed

by $0.01

Q4'25

Est.

$-0.07

Q3'25

Est.

$-0.08

Q2'25

Est.

$-0.07

The last earnings report on May 14 showed earnings per share of -5 cents, missing the estimate of -5 cents. With 11.68K shares outstanding, the current market capitalization sits at 4.12M.

View a ticker or compare two or three

JUNS

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for JUNS